One of the most rampant diseases that we are dealing with in America right now is cancer in all of its various forms. Nearly 40 percent of adults in the U.S. will face a cancer diagnosis within their life and almost everyone knows of someone who has gone through the cancer fight themselves.
One of the prevalent issues with cancer and its treatment stems from the flow of information and has been seriously impeded for decades. Much of the most vital information regarding a patient and their treatment is done by hand by the physician in a blank space set aside for this purpose. The problem has been how to effectively streamline that data into a collective database.
That problem is quickly seeing a solution with Tempus, Co-founded by Eric Lefkofsky. Tempus is a revolutionary company that is serving a variety of needs within the medical field. One of the most impactful ways that Tempus is changing how cancer treatments are being delivered is through the optical recognition and scanning of native handwriting.
This new scanning process enables Tempus to read the physician’s hand-written notes on the patient and store them into a database in an easily read format. This alone will branch out of cancer treatment alone and will change the way a range of diseases will be monitored and treated.
Another profound way that Tempus is helping to change the way that cancer treatment is being administered is through the ability to scan and store collected data on human genome mapping. This is important because almost all cancer research today is being done on how to treat and even prevent the disease on a molecular level.
Eric Lefkofsky graduated from the University of Michigan in Ann Arbor and went on to receive his Juris Doctor degree from the University of Michigan Law School but his path in life would not take him down the legal road.
Eric was swept up in the dot-com revolution and before long he found himself to be a power player and it was when his wife was diagnosed with breast cancer when he saw the huge gap in the medical field and how to bridge it.